Lynparza Description

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Description

Lynparza 100 mg film-coated tablets: Yellow to dark yellow, oval, bi-convex tablet, debossed with 'OP100' on one side and plain on the other side.
Each film-coated tablet contains 100 mg olaparib.
Lynparza 150 mg film-coated tablets: Green to green/grey, oval, bi-convex tablet, debossed with 'OP150' on one side and plain on the other side.
Each film-coated tablet contains 150 mg olaparib.
Excipient with known effect: This medicinal product contains 0.24 mg sodium per 100 mg tablet and 0.35 mg sodium per 150 mg tablet.
Excipients/Inactive Ingredients: Tablet core: Copovidone, Colloidal anhydrous silica, Mannitol, Sodium stearyl fumarate.
Tablet coating: Hypromellose, Macrogol 400, Titanium dioxide (E171), Iron oxide yellow (E172), Iron oxide black (E172) (150 mg tablets only).

Manufacturer:

AstraZeneca

Distributor:

Zuellig

Four Star